Document is current

Article History

Received: 8 February 2025

Accepted: 17 March 2025

First Online: 7 April 2025

Declarations

:

: This study is centrally approved by the Ontario Central Research Ethics Board (OCREB; approval number CTO4663) and by Lawson Research Ethics Board (approval number R-24-092). All participants provided informed consent before taking part in the research, and the study adhered to the ethical guidelines outlined in the Declaration of Helsinki.

: All participants will be required to provide explicit consent for their anonymized data and any relevant findings to be published in scientific journals and other scholarly outlets. This consent will be obtained as part of the informed consent process before data collection.

: Written, informed consent will be obtained from all participants prior to enrolment. Patients enrolled will be informed of all aspects of the study, including the potential risks and benefits involved. They will be given sufficient time and opportunity to ask questions prior to deciding about participating in the study and be informed that participation in the study is voluntary and that they are completely free to refuse to enter the study or to withdraw from it at any time, for any reason.

: This study does not require a data safety monitoring board.

: The authors declare no competing interests.